Literature DB >> 25371205

Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH.

Adriana Badarau1, Harald Rouha1, Stefan Malafa1, Derek T Logan2, Maria Håkansson2, Lukas Stulik1, Ivana Dolezilkova1, Astrid Teubenbacher1, Karin Gross1, Barbara Maierhofer1, Susanne Weber1, Michaela Jägerhofer1, David Hoffman1, Eszter Nagy3.   

Abstract

The bi-component leukocidins of Staphylococcus aureus are important virulence factors that lyse human phagocytic cells and contribute to immune evasion. The γ-hemolysins (HlgAB and HlgCB) and Panton-Valentine leukocidin (PVL or LukSF) were shown to assemble from soluble subunits into membrane-bound oligomers on the surface of target cells, creating barrel-like pore structures that lead to cell lysis. LukGH is the most distantly related member of this toxin family, sharing only 30-40% amino acid sequence identity with the others. We observed that, unlike other leukocidin subunits, recombinant LukH and LukG had low solubility and were unable to bind to target cells, unless both components were present. Using biolayer interferometry and intrinsic tryptophan fluorescence we detected binding of LukH to LukG in solution with an affinity in the low nanomolar range and dynamic light scattering measurements confirmed formation of a heterodimer. We elucidated the structure of LukGH by x-ray crystallography at 2.8-Å resolution. This revealed an octameric structure that strongly resembles that reported for HlgAB, but with important structural differences. Structure guided mutagenesis studies demonstrated that three salt bridges, not found in other bi-component leukocidins, are essential for dimer formation in solution and receptor binding. We detected weak binding of LukH, but not LukG, to the cellular receptor CD11b by biolayer interferometry, suggesting that in common with other members of this toxin family, the S-component has the primary contact role with the receptor. These new insights provide the basis for novel strategies to counteract this powerful toxin and Staphylococcus aureus pathogenesis.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Bacterial Toxin; Crystal Structure; Crystallography; Microbial Pathogenesis; Mutagenesis; Staphylococcus aureus (S. aureus)

Mesh:

Substances:

Year:  2014        PMID: 25371205      PMCID: PMC4281717          DOI: 10.1074/jbc.M114.598110

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Essential residues, W177 and R198, of LukF for phosphatidylcholine-binding and pore-formation by staphylococcal gamma-hemolysin on human erythrocyte membranes.

Authors:  Naota Monma; Vananh T Nguyen; Jun Kaneko; Hideo Higuchi; Yoshiyuki Kamio
Journal:  J Biochem       Date:  2004-10       Impact factor: 3.387

2.  Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition.

Authors:  Ashley L DuMont; Pauline Yoong; Xiang Liu; Christopher J Day; Nicole M Chumbler; David B A James; Francis Alonzo; Nadine J Bode; D Borden Lacy; Michael P Jennings; Victor J Torres
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

3.  A simple method of markerless gene deletion in Staphylococcus aureus.

Authors:  Fuminori Kato; Motoyuki Sugai
Journal:  J Microbiol Methods       Date:  2011-07-23       Impact factor: 2.363

4.  A new bioinformatics analysis tools framework at EMBL-EBI.

Authors:  Mickael Goujon; Hamish McWilliam; Weizhong Li; Franck Valentin; Silvano Squizzato; Juri Paern; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2010-05-03       Impact factor: 16.971

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 6.  Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids.

Authors:  Ashley L DuMont; Victor J Torres
Journal:  Trends Microbiol       Date:  2013-11-11       Impact factor: 17.079

7.  CCR5 is a receptor for Staphylococcus aureus leukotoxin ED.

Authors:  Francis Alonzo; Lina Kozhaya; Stephen A Rawlings; Tamara Reyes-Robles; Ashley L DuMont; David G Myszka; Nathaniel R Landau; Derya Unutmaz; Victor J Torres
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962

8.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

9.  The macromolecular crystallography beamline I911-3 at the MAX IV laboratory.

Authors:  Thomas Ursby; Johan Unge; Roberto Appio; Derek T Logan; Folmer Fredslund; Christer Svensson; Krister Larsson; Ana Labrador; Marjolein M G M Thunnissen
Journal:  J Synchrotron Radiat       Date:  2013-05-18       Impact factor: 2.616

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  22 in total

Review 1.  The role of genetics and antibodies in sepsis.

Authors:  Evangelos J Giamarellos-Bourboulis; Steven M Opal
Journal:  Ann Transl Med       Date:  2016-09

Review 2.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

3.  Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.

Authors:  Isaac P Thomsen; Gopal Sapparapu; David B A James; James E Cassat; Meera Nagarsheth; Nurgun Kose; Nicole Putnam; Kristina M Boguslawski; Lauren S Jones; James B Wood; Clarence B Creech; Victor J Torres; James E Crowe
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

Review 4.  Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.

Authors:  András N Spaan; Jos A G van Strijp; Victor J Torres
Journal:  Nat Rev Microbiol       Date:  2017-04-19       Impact factor: 60.633

5.  Unbiased Identification of Immunogenic Staphylococcus aureus Leukotoxin B-Cell Epitopes.

Authors:  David N Hernandez; Kayan Tam; Bo Shopsin; Emily E Radke; Pegah Kolahi; Richard Copin; François-Xavier Stubbe; Timothy Cardozo; Victor J Torres; Gregg J Silverman
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

6.  Structure-based discovery of a small-molecule inhibitor of methicillin-resistant Staphylococcus aureus virulence.

Authors:  Jie Liu; Lina Kozhaya; Victor J Torres; Derya Unutmaz; Min Lu
Journal:  J Biol Chem       Date:  2020-03-16       Impact factor: 5.157

Review 7.  Inflammasome Activation Can Mediate Tissue-Specific Pathogenesis or Protection in Staphylococcus aureus Infection.

Authors:  Jason H Melehani; Joseph A Duncan
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

8.  Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis.

Authors:  Tamara Reyes-Robles; Ashira Lubkin; Francis Alonzo; D Borden Lacy; Victor J Torres
Journal:  EMBO Rep       Date:  2016-02-08       Impact factor: 8.807

9.  Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular.

Authors:  Jason H Melehani; David B A James; Ashley L DuMont; Victor J Torres; Joseph A Duncan
Journal:  PLoS Pathog       Date:  2015-06-12       Impact factor: 6.823

Review 10.  Antimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus.

Authors:  Ronald S Flannagan; Bryan Heit; David E Heinrichs
Journal:  Pathogens       Date:  2015-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.